Loading live market data…

ChitogenX Inc.

OTC:CHNXF

$0.00755 USD

$0 (0.0%)

Volume
50K
Average Volume
30.05K
Market Capitalization
$627.63K
P/E Ratio
-0.23
Dividend Yield
0.00%
Price Target
$
Year High
$0.02
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.07

Industry, Sector & symbol

Stock Exchange OTC
CEO Pierre Laurin
Industry Biotechnology
Sector Healthcare
Current Symbol CHNXF
CUSIP 169916103
CIK None
Web https://www.chitogenx.com
Phone 514-782-0951
Currency USD
Employees 5
Country CA

Liquidity

Debt-to-Equity Ratio -0.63
Payout Ratio 0.00
Current Ratio 0.07
Quick Ratio 0.07
Cash Ratio 0.01

Sales & Book Value

Annual Sales $-
Price / Sales 0.00
Cash Flow -0.01
Price / Cash Flow -0.41
Price / Book -0.06

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0213
Trailing P/E Ratio -0.23
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-1.55M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity 19.40%
Return on Assets -291.01%

Financials Score

AltmanZ Score -135.21
Piotroski Score 2.00
Working Capital -7.52M
Total Assets 385K
Ebit -1.25M
Market Cap 888.55K
Total Liabilities 7.75M

Poll Results

About ChitogenX Inc. (OTC:CHNXF) Stock

ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialized products: Ortho-R, a specific formulation designed for rotator cuff injuries; Ortho-M, a biopolymer addressing meniscus repair; Ortho-C, another biopolymer for the regeneration of articular cartilage; and Ortho-V, a biopolymer developed to facilitate the healing of osteoarthritis. Additionally, they are advancing ORTHO-T, a biopolymer formulation engineered for tendon healing and regeneration. Previously known as Ortho Regenerative Technologies In ... c., the company adopted its current name, ChitogenX Inc., in September of 2022. Established in 2015, ChitogenX maintains its headquarters in Kirkland, Canada.

Frequently Asked Questions

What is the current ChitogenX Inc. (CHNXF) stock price?

ChitogenX Inc.(OTC:CHNXF) stock price is $0.00755 in the last trading session. During the trading session, CHNXF stock reached the peak price of $0.0165 while $0.0011 was the lowest point it dropped to. The percentage change in CHNXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHNXF stock was $0.

CHNXF's industry and sector of operation?

The OTC listed CHNXF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of CHNXF?

Guy-Paul Allard | Vice President of Legal Affairs & Corporate Secretary
Luc Mainville | Senior Vice President & Chief Financial Officer
Frédéric Dumais | Director of Communications & Investor Relations
Jonathan Sackier | Senior Vice President of Medical Affairs
Pierre Laurin | Interim Chief Executive Officer & Chairman

How many employees does CHNXF have?

Number of CHNXF employees currently stands at 5. CHNXF operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.

Link for CHNXF official website?

Official Website of CHNXF is: https://www.chitogenx.com

How do I contact CHNXF?

CHNXF could be contacted at phone #514-782-0951 and can also be accessed through its website. CHNXF operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.

How many shares of CHNXF are traded daily?

The average number of CHNXF shares traded daily for last 3 months was 30.05K.

What is the market cap of CHNXF currently?

The market value of CHNXF currently stands at $627.63K with its latest stock price at $0.00755